Regeneron Pharmaceuticals, Inc.
2021 Q4 - 2026 Q1 (18 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 4/8/2026 | 7,637 | 0.2% | 10,024 | 3/31/2026 |
| 2025 Q4 | 1/8/2026 | 9,755 | 0.2% | 12,782 | 12/31/2025 |
| 2025 Q3 | 10/29/2025 | 6,938 | 0.2% | 11,896 | 9/30/2025 |
| 2025 Q2 | 7/10/2025 | 6,324 | 0.2% | 11,554 | 6/30/2025 |
| 2025 Q1 | 4/16/2025 | 7,549 | 0.2% | 11,903 | 3/31/2025 |
| 2024 Q4 | 3/17/2025 | 8,082 | 0.2% | 11,346 | 12/31/2024 |
| 2024 Q3 | 10/24/2024 | 11,644 | 0.4% | 11,076 | 9/30/2024 |
| 2024 Q2 | 7/16/2024 | 11,357 | 0.4% | 10,805 | 6/30/2024 |
| 2024 Q1 | 4/15/2024 | 10,153 | 0.3% | 10,549 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 9,139 | 0.3% | 10,406 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 8,580 | 0.3% | 10,426 | 9/30/2023 |
| 2023 Q2 | 7/21/2023 | 7,507 | 0.3% | 10,447 | 6/30/2023 |
| 2023 Q1 | 4/25/2023 | 8,476 | 0.4% | 10,315 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 7,070 | 0.4% | 9,799 | 12/31/2022 |
| 2022 Q3 | 10/19/2022 | 7,170 | 0.4% | 10,408 | 9/30/2022 |
| 2022 Q2 | 7/18/2022 | 6,100 | 0.3% | 10,320 | 6/30/2022 |
| 2022 Q1 | 4/18/2022 | 7,313 | 0.3% | 10,471 | 3/31/2022 |
| 2021 Q4 | 2/9/2022 | 6,245 | 0.3% | 9,889 | 12/31/2021 |